Skip to main content

Orchid Taps George Poste to Replace Pfost as Chairman

NEW YORK, Oct. 9 - Orchid BioSciences has tapped George Poste to be its new chairman. He replaces Dale Pfost, who remains as Orchid's president and CEO.

Poste, 58, is the former president of R&D and chief science and technology officer at SmithKline Beecham, and current CEO of Health Technology Networks. He has been a member of Orchid's board of directors since April 2000.


Click here for more information.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.